000			03414cam a2200229 4500
001			9780323485289
008			220107t2019 xxu||||| |||| 00| 0 eng d
020			_a9780323485289
020			_a9780323485289
041			_aeng
100			_aJames, Kaitlin C.
245		0	_aFenichel's clinical pediatric neurology: a signs and symptoms approach
250			_a8th ed.
260			_aPhiladelphia : _bElsevier, _c2019
300			_a1 online resource (v, 364 pages):illustrations (some color)
490			_aClinicalKey
505			_aParoxysmal disorders -- Altered states of consciousness -- Headache -- Increased intracranial pressure -- Psychomotor retardation and regression -- The hypotonic infant -- Flaccid limb weakness in childhood -- Cramps, muscle stiffness, and exercise intolerance -- Sensory and autonomic disturbances -- Ataxia -- Hemiplegia -- Paraplegia and quadriplegia -- Monoplegia -- Movement disorders -- Disorders of ocular motility -- Disorders of the visual system -- Lower brainstem and cranial nerve dysfunction -- Disorders of cranial volume and shape.
520			_aTaking a practical, easy-to-reference signs and symptoms approach, Fenichel's Clinical Pediatric Neurology, 8th Edition, provides a solid foundation in the diagnosis and management of primary neurologic disorders of childhood while bringing you fully up to date with recent developments in the field. It offers step-by-step, authoritative guidance that considers each presenting symptom in terms of differential diagnosis and treatment, reflecting real-life patient evaluation and management. Perfect for board exam preparation, office use, or residency reference, this well-organized, revised edition is an ideal introduction to this complex and fast-changing field. Includes a new chapter on genetics in relation to epilepsy, autism, and many neurometabolic disorders, with up-to-date coverage of genetic testing, diagnosis, and pharmacogenomics. Brings you up to date with the new definition of status epilepticus; new guidelines for Lennox Gastaut syndrome; new FDA-approved drugs for epilepsy, ADHD, dystonia, and more; new data on sudden infant death syndrome; and revised consensus criteria which unifies the concepts of neuromyelitis optica (NMO) and neuromyelitis optica spectrum disorders (NMOSD). Defines age at onset, course of illness, clinical features, and treatment options for each neurological disease, all logically organized by neurological signs and symptoms in a highly templated format. Features weighted differential diagnosis tables and treatment algorithms that help you quickly identify the more common and most treatable neurological disorders, as well as evaluate and manage the most difficult neurodegenerative disorders, including those caused by inborn errors of metabolism. Shares the knowledge and experience of Dr. J. Eric Pina-Garza, MD, a longtime associate and protegeü of Dr. Gerald Fenichel, and Dr. Kaitlin C. James, Medical Director of the Pediatric Epilepsy Monitoring Unit at Vanderbilt Children's Hospital. Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
690			_aPediatric neurology.
856			_uhttps://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C2015006960X
999			_c58328 _d58328